Products

Description

GLYCIPHAGE^® contains the active ingredient Metformin Hydrochloride, an oral anti-diabetic drug belonging to the biguanide class of molecules that decrease glucose production by the liver.

GLYCIPHAGE^®overcomes insulin resistance and it has an extra-pancreatic peripheral action. GLYCIPHAGE^®does not produce hypoglycaemia in either diabetic or non-diabetic subjects and does not cause hyperinsulinemia.

GLYCIPHAGE^® is indicated as an adjunct to diet and exercise, to improve glycaemic control in adults and children (13 years and above) with type 2 diabetes mellitus.

GLYCIPHAGE^® can be used concomitantly with a Sulphonylureas, Thiazolidinediones, Gliptin, Glitazone, Alpha-glucosidase inhibitor or Insulin to improve glycaemic control.

Metformin GLYCIPHAGE^® therapy for prevention of type 2 diabetes should be considered in those with prediabetes, especially for those with BMI$35 kg/m2, those aged ,60 years, and women with prior gestational diabetes mellitus

phentermine375usa.com

GLYCIPHAGE^® GLYCIPHAGE 850^® GLYCIPHAGE 250^®TABLETS

(ORAL ANTI-HYPERGLYCEMIC AGENT)

Composition

GLYCIPHAGE^®

Each uncoated tablet contains:
Metformin Hydrochloride I.P. ........................................500 mg.
Excipients ..................................................................... q.s.

GLYCIPHAGE^® 850

Each uncoated tablet contains:
Metformin Hydrochloride I.P. ....................................... 850 mg.
Excipients ..................................................................... q.s.

GLYCIPHAGE^® 250

Each uncoated tablet contains:
Metformin Hydrochloride I.P. ........................................250 mg.
Excipients ..................................................................... q.s.